Two Sigma Securities’s BioCardia BCDA Stock Holding History

Two Sigma Securities’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,780	Closed	-$17.9K	–	1743
2026 Q1	$17.9K	Buy	+14,780	New	+$18.5K	﹤0.01%	1389
2025 Q4	–	Sell	-19,337	Closed	-$24.9K	–	1483
2025 Q3	$24.9K	Buy	+19,337	New	+$37.8K	﹤0.01%	1097
2024 Q2	–	Sell	-7,405	Closed	-$45.2K	–	2981
2024 Q1	$45.2K	Buy	+7,405	New	+$53.1K	﹤0.01%	2577
2022 Q1	–	Sell	-1,413	Closed	-$41K	–	2111
2021 Q4	$41K	Buy	+1,413	New	+$51.8K	﹤0.01%	1304

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Two Sigma Securities's BCDA Position: Q2 2026 in Review

Two Sigma Securities sold out of BioCardia (BCDA) in Q2 2026, closing a stake of 14,780 shares — an estimated $17.9K sold.

Two Sigma Securities first reported a position in BCDA in Q4 2021 and held it in 4 quarters. The position peaked at $45.2K in Q1 2024. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Two Sigma Securities reported no remaining BioCardia position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 14,780 BioCardia shares in Q2 2026, an estimated $17.9K.
Two Sigma Securities first reported a position in BioCardia in Q4 2021 and held it in 4 quarters.
Two Sigma Securities's BioCardia position peaked at $45.2K in Q1 2024.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.